Terms: = Pancreatic cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
34 results:
1. Beta-cell death and dysfunction drives hyperglycaemia in organ donors.
Shapey IM; Summers A; O'Sullivan J; Fullwood C; Hanley NA; Casey J; Forbes S; Rosenthal M; Johnson PRV; Choudhary P; Bushnell J; Shaw JAM; Neiman D; Shemer R; Glaser B; Dor Y; Augustine T; Rutter MK; van Dellen D
Diabetes Obes Metab; 2023 Dec; 25(12):3529-3537. PubMed ID: 37646197
[TBL] [Abstract] [Full Text] [Related]
2. hmga1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
Chia L; Wang B; Kim JH; Luo LZ; Shuai S; Herrera I; Chen SY; Li L; Xian L; Huso T; Heydarian M; Reddy K; Sung WJ; Ishiyama S; Guo G; Jaffee E; Zheng L; Cope LM; Gabrielson K; Wood L; Resar L
J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36919699
[TBL] [Abstract] [Full Text] [Related]
3. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/hmga1 axis.
Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
[TBL] [Abstract] [Full Text] [Related]
4. hmga1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.
Saed L; Balcerczak E; Łochowski M; Olechnowicz E; Sałagacka-Kubiak A
Mol Genet Genomics; 2022 Nov; 297(6):1505-1514. PubMed ID: 35948739
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
6. The role of hmga1 protein in gastroenteropancreatic neuroendocrine tumors.
De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
[TBL] [Abstract] [Full Text] [Related]
7. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of pancreatic cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating hmga1.
Shen R; Wang X; Wang S; Zhu D; Li M
Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
[TBL] [Abstract] [Full Text] [Related]
8. RETRACTED: pancreatic cancer cells-derived exosomal long non-coding RNA CCAT1/microRNA-138-5p/hmga1 axis promotes tumor angiogenesis.
Han W; Sulidankazha Q; Nie X; Yilidan R; Len K
Life Sci; 2021 Aug; 278():119495. PubMed ID: 33872661
[TBL] [Abstract] [Full Text] [Related]
9. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.
Chiou SH; Dorsch M; Kusch E; Naranjo S; Kozak MM; Koong AC; Winslow MM; Grüner BM
Sci Rep; 2018 Sep; 8(1):14008. PubMed ID: 30228296
[TBL] [Abstract] [Full Text] [Related]
10. Abdominal skin closure using subcuticular sutures prevents incisional surgical site infection in hepatopancreatobiliary surgery.
Okubo S; Gotohda N; Sugimoto M; Nomura S; Kobayashi S; Takahashi S; Hayashi R; Konishi M
Surgery; 2018 Aug; 164(2):251-256. PubMed ID: 29803560
[TBL] [Abstract] [Full Text] [Related]
11. A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic hmga1 as a new cancer treatment therapy.
Hassan F; Lossie SL; Kasik EP; Channon AM; Ni S; Kennedy MA
PLoS One; 2018; 13(2):e0192882. PubMed ID: 29462157
[TBL] [Abstract] [Full Text] [Related]
12. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
[TBL] [Abstract] [Full Text] [Related]
13. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National cancer Data Base.
Colbert LE; Hall WA; Nickleach D; Switchenko J; Kooby DA; Liu Y; Gillespie T; Lipscomb J; Kauh J; Landry JC
Cancer; 2014 Feb; 120(4):499-506. PubMed ID: 24390739
[TBL] [Abstract] [Full Text] [Related]
14. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
[TBL] [Abstract] [Full Text] [Related]
15. The hmga1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
[TBL] [Abstract] [Full Text] [Related]
16. hmga1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract] [Full Text] [Related]
17. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
Li W; Yuan Y; Huang L; Qiao M; Zhang Y
Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
[TBL] [Abstract] [Full Text] [Related]
18. Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (hmga1) reduce tumor growth in vivo.
Maasch C; Vater A; Buchner K; Purschke WG; Eulberg D; Vonhoff S; Klussmann S
J Biol Chem; 2010 Dec; 285(51):40012-8. PubMed ID: 20961861
[TBL] [Abstract] [Full Text] [Related]
19. Differential expression and prognostic value of hmga1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract] [Full Text] [Related]
20. High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
Liau SS; Whang E
Surgeon; 2009 Oct; 7(5):297-306. PubMed ID: 19848064
[TBL] [Abstract] [Full Text] [Related]
[Next]
